Modulation of Therapeutic Response
Modulation of Therapeutic Response
批准号:
8554011
负责人:
James Mitchell
金额:
$66.27万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AttentionBlood - brain barrier anatomyBrainCell CycleCell LineCisplatinClinical DataClinical TrialsColon CarcinomaCommiphora mukulDNA Double Strand BreakDataDoseDouble Strand Break RepairFGF7 geneGene TransferGoalsHead and Neck CancerHumanHypolipidemic AgentsIGF1 geneIonizing radiationMCF7 cellModificationMolecularMovementMucositisMusNF-kappa BNormal tissue morphologyPancreasPhysiologyPlant ResinsProcessProteinsRadiationRadiation OncologyRadiation ToleranceRadiation-Protective AgentsReportingResearchResearch DesignResistanceSubmandibular glandTherapeuticTopical applicationToxic effectTranslatingTreesTumor-Associated Processcancer cellcancer therapycell growthchemotherapyclinical applicationgugulu extracthuman ESR1 proteinimprovedinhibitor/antagonistinterestkeratinocyte growth factornoveloral mucositispancreatic cancer cellspre-clinicalpre-clinical researchradiation effectresponsetempoltreatment responsetumortumor growth
中文摘要
为了提高癌症的治疗水平,辐射损伤的修饰受到了极大的关注。各种化疗和/或分子靶向药物与辐射的相互作用正在研究中,以确定是否可以使肿瘤更敏感,或使正常组织对放射治疗更具抵抗力。中心目标是确定将导致净治疗收益的方法,从而改善癌症的放射治疗。该项目的目标之一是定义和更好地了解肿瘤生理学的这些方面,包括细胞和分子过程以及肿瘤微环境对治疗反应的影响。增强肿瘤对辐射的反应,而不增强给定治疗范围内的正常组织的能力是可取的。Gugglesterone是香附树脂的一种衍生物,已被广泛报道为降血脂药物,最近又被报道为核因子-kB激活的抑制剂。研究发现,桂皮酮可抑制胰腺癌细胞株PC-SW对辐射诱导的核因子-kB的激活,并增强其对辐射的敏感性。Gugglesterone减少了MCF7细胞的细胞周期运动和细胞生长,减少了结肠癌细胞和胰腺癌细胞的ERα蛋白和IGF1-Rβ蛋白,并抑制了辐射后DNA双链断裂(DSB)修复。在正常组织对辐射的反应方面,我们发现,将角质形成细胞生长因子(KGF)基因转移到小鼠颌下腺可以提供显著的保护,对单次和分次剂量的辐射都有保护作用。局部基因转移导致了显著的全身水平的KGF;然而,KGF基因转移对肿瘤的生长没有影响,无论有没有放射治疗。这些数据提示了潜在的临床应用。我们还表明,氮氧化物,坦普尔,预防辐射诱导的口腔粘膜炎(全身和局部应用)。口腔粘膜炎是头颈癌放化疗(顺铂联合分次放疗)治疗的常见毒性反应。坦波尔还可以预防放化疗引起的粘膜炎,但不会改变放化疗对肿瘤再生延迟的影响,这为将坦波尔引入人类放射肿瘤学临床试验提供了足够的临床前数据。最后,一种新的五元环氮氧化合物(23c)被证明是有效的保护剂,防止辐射诱导的小鼠死亡,并计划进行研究,以确定是否可以在选定的小鼠正常组织中观察到保护作用,尤其是脑,因为氮氧化物穿透血脑屏障。
英文摘要
SummaryIn the interest of improving cancer treatment, considerable attention has been placed on the modification of radiation damage. The interaction of a variety of chemotherapy and/or molecularly targeted agents with radiation is under study to determine if tumors can be made more sensitive or normal tissues more resistant to radiation treatment. The central aim is to identify approaches that will result in a net therapeutic gain, thus improving cancer treatment with radiation. One goal of the project is to define and better understand those aspects of tumor physiology, including cellular and molecular processes and the influence of the tumor microenvironment on treatment response. The ability to enhance the response of the tumor to radiation, without enhancing normal tissue within a given treatment field is desirable. Gugglesterone, a derivative of the resin of guggul tree Commiphora mukul has been widely reported as a hypolipidemic agent and more recently as an inhibitor of NF-kB activation. It was found that gugglesterone inhibited radiation-induced NF-kB activation and enhanced radiosensitivity in the pancreatic cell line, PC-Sw. Gugglesterone reduced both cell cycle movement and cell growth and reduced ER alpha protein in MCF7 cells and IGF1-R beta protein in colon cancer cells and pancreatic cancer cells and inhibited DNA double strand break (DSB) repair following radiation. With respect to normal tissue response to radiation, we found that keratinocyte growth factor (KGF) gene transfer to mouse submandibular glands afforded significant protection against both single and fractionated doses of radiation. Local gene transfer resulted in significant systemic levels of KGF; however, KGF gene transfer had no effect on tumor growth with or without radiation. These data suggest potential clinical application. We have also shown that the nitroxide, Tempol protects against radiation-induced oral mucositis (both systemic and topically applied). Oral mucositis is a common toxicity associated with the chemoradiation (cisplatin combined with fractionated radiation) treatment of head and neck cancers. Tempol also protects against chemoradiation-induced mucositis yet did not alter chemoradiation with respect to tumor regrowth delay, providing sufficient pre-clinical data to introduce Tempol into human radiation oncology clinical trials.Lastly, a novel 5-membered ring nitroxide (23c) was shown to be a potent protector against radiation-induced lethality in mice and studies are planned to determine if protection can be observed in selected normal tissues in mice, particularly the brain since the nitroxide penetrates the blood brain barrier.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nitroxides as Protectors Against Oxidative Stress
-
批准号:10487178
-
项目类别:
-
资助金额:$23.68万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:9154244
-
项目类别:
-
资助金额:$67.78万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:8349242
-
项目类别:
-
资助金额:$32.13万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Redox Imaging using Nitroxides and MRI
-
批准号:8349161
-
项目类别:
-
资助金额:$55.7万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:8350044
-
项目类别:
-
资助金额:$70.69万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:10702438
-
项目类别:
-
资助金额:$114.64万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:8938387
-
项目类别:
-
资助金额:$63.42万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10262691
-
项目类别:
-
资助金额:$138.88万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:10262693
-
项目类别:
-
资助金额:$27.78万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:8158259
-
项目类别:
-
资助金额:$64.92万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:9153721
-
项目类别:
-
资助金额:$65.79万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Protection against Radiation-Induced Carcinogenesis
-
批准号:8937900
-
项目类别:
-
资助金额:$63.42万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:10926566
-
项目类别:
-
资助金额:$58.43万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10487176
-
项目类别:
-
资助金额:$118.41万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Imaging Probe Development Center
-
批准号:8746870
-
项目类别:
-
资助金额:$370.3万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Redox Imaging using Nitroxides and MRI
-
批准号:8552827
-
项目类别:
-
资助金额:$30.12万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Redox Imaging using Nitroxides and MRI
-
批准号:7592935
-
项目类别:
-
资助金额:$31.76万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10702987
-
项目类别:
-
资助金额:$143.3万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Modulation of Therapeutic Response
-
批准号:10926564
-
项目类别:
-
资助金额:$175.3万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位:
Nitroxides as Protectors Against Oxidative Stress
-
批准号:8763677
-
项目类别:
-
资助金额:$54.34万
-
财政年份:--
-
负责人:James Mitchell
-
依托单位: